View up-to-date information on Shenzhen Hepalink Pharmaceutical Group Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 05 May 2021 | Resverlogix Raises USD6 Million in Private Placement of 10% Debentures due 2022 | Debt Offering |
Shenzhen Hepalink Pharmaceutical Group Co Ltd
|
Resverlogix Corp
|
| 01 Mar 2021 | CARISMA Therapeutics Raises USD59 Million in Series B Financing | Venture Financing |
IP Group Inc
Livzon Pharmaceutical Group Co Ltd
Penn Medicine
MRL Ventures Fund LLC
SymBiosis II LLC
Solasta Ventures
Agent Capital LLC
4BIO Ventures Management Ltd
HealthCap LLC
Wellington Partners
AbbVie Ventures
Tpg Biotechnology Partners IV LP
|
Carisma Therapeutics Inc
|
| 27 Aug 2020 | Theramex Ireland Enters API Manufacturing Agreement with Cytovance Biologics for Livogiva | Contract Service Agreement |
Theramex Ireland Ltd
|
Cytovance Biologics Inc
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer